This contract is an SBIR Phase I award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Giner Inc., a Boston-based research and development firm. The contract, valued at $149,983.00, is for a Small Business Innovation Research (SBIR) project and does not have a set-aside designation. Giner Inc. is a for-profit, subchapter S corporation that specializes in developing cutting-edge electrochemical technologies, including those for clean energy,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Navy Naval Sea Systems Command to Giner Inc., a Boston-based research and development firm. The $239,999 firm-fixed-price contract is for the development of cutting-edge electrochemical technologies, including clean energy, biomedical engineering, and environmental applications. Giner Inc. has previously received federal R&D contracts from agencies such as NASA, the Department of Defense,...
This is a $222,608 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Giner Inc., a Boston-based research and development firm. The contract is for the "Development of a pO2 Guided Core Needle Tumor Biopsy Device" under SBIR Topic 331. Giner Inc. is a for-profit, Subchapter S Corporation that has extensive experience delivering research, prototypes, and products to federal agencies like NASA, the Department of Defense, and the...
This is a $1,099,888.52 Firm Fixed Price definitive contract awarded by the Defense Health Agency (DHA) to Giner Inc., a Boston-based research and development firm focused on electrochemical technologies. The contract is for a STTR Phase II effort titled "Rapid and Reprogrammable Assay for Multiplexed Gene Detection." This Small Business set-aside contract supports the DHA's medical research and development mission, with an ultimate completion date of November 13, 2025. Giner Inc....
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a Cost Plus Fixed Fee definitive contract to Giner Inc., a Boston-based research and development firm, for RESEARCH AND DEVELOPMENT FACILITIES. The contract has a potential value of $1,500,000.00 and does not have a set-aside designation. Giner Inc. is a for-profit Subchapter S Corporation that has extensive experience in developing cutting-edge...
This is a $299,966.00 firm fixed-price SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Giner Inc., a small business research and development firm based in Boston. The contract is for the development of point-of-care monitoring technologies to assess adherence to antiretroviral HIV therapy. The original contract opportunity was part of a broader SBIR solicitation from the National Institutes of Health (NIH) and Centers for Disease Control...
This is a $299,633 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "smartphone-integrated point-of-care sensor for rapid and sensitive detection of malaria in low-resource applications." Giner Inc. has experience delivering technology...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Giner Inc., a Boston-based research and development firm. The contract has a value of $995,662.27 and a completion date of August 5, 2020. Giner Inc. is a small business that has received numerous federal contracts and grants from agencies such as NASA, the Department of Defense, and the Department of Energy, to develop advanced technologies...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a Small Business Innovation Research (SBIR) Phase I contract to (Ad)2 Technologies, a woman-owned small business, for a wearable alcohol biosensor that quantifies blood alcohol content (BAC) in real-time. The firm-fixed-price contract has a potential value of $499,997.00 and a completion date of July 24, 2020. The SBIR program supports research and...
This is a SBIR Phase II contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Giner Inc., a Boston-based research and development firm. The $999,518.00 cost-plus-fixed-fee contract has a completion date of March 4, 2020 and does not have a set-aside designation. Giner Inc. is a for-profit subchapter S corporation that has received numerous federal contracts and grants from agencies like NASA, the Department of Defense, the Department of...